Menten AI

Menten AI is pioneering the development of protein therapeutics and enzymes through the application of quantum computing and advanced machine learning techniques. Their innovative approach surpasses existing computational methodologies, enabling the design of proteins that were previously considered too complex to engineer. Menten AI has developed a groundbreaking protein design algorithm specifically tailored for both current and emerging quantum computing platforms. Notably, they achieved a significant milestone by creating the world's first protein designed using a quantum computer. Currently, the company is focused on developing three novel proteins, including a peptide designed to inhibit the spread of viruses such as Covid-19. Menten AI has secured two paid pilot projects with prominent multinational chemical corporations and has established four Letters of Intent (LOIs) with leading pharmaceutical and biotechnology companies, indicating strong market interest and potential for future growth.